Andrea Olariu
CEO · Medicines360
CEO at Medicines360. Listed as an officer, director, or key employee across 1 organization on the Form 990 record.
This is meWho this is
Profile
The filed facts are verified from the IRS filings. The biography is compiled from public web sources and grounded to that filed record.
Dr. Andrea Olariu, MD, PhD, is the Chief Executive Officer of Medicines360, appointed in May 2023.
She holds a medical degree in dermatology and a PhD in immunology, and has authored over 40 peer-reviewed articles. She has been with Medicines360 since 2010, holding leadership roles in clinical affairs, regulatory strategy, and product development, and led the clinical and regulatory strategy for FDA approval of LILETTA, the organization's hormonal intrauterine device.
Track record
Career & tenure
Real tenure, career, and education — from public web sources, what you need to vet a founder or leader beyond the filing window.
- MD Dermatology
- PhD Immunology
- University of Szeged (Associate Professor of Dermatology)
- Romania (Senior Lecturer of Immunology) · Victor Babes University of Medicine and Pharmacy, Timisoara
Verify independently
Find them online
Primary links to check this person directly — their own pages, not an aggregator.
Affiliations
Organizations
Network
Serves alongside
Other officers, directors & key employees at this person's organizations, by latest reported compensation.
Network
Recommendations
Written by other verified members of the network — visible once you're a verified person yourself.
Loading…
People like this
Similar leaders
Leaders at organizations in the same field, by reported compensation.